MiMedx Group (MDXG) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for June 18, 2025, with virtual attendance available for shareholders.
Shareholders are encouraged to review proxy materials and vote by June 17, 2025, 11:59 PM ET.
Voting matters and shareholder proposals
Election of eight directors is on the agenda, with all nominees recommended by the board.
Advisory approval of executive compensation is proposed.
Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2025.
Amendment to the 2016 Equity and Cash Incentive Plan is up for vote.
Advisory vote on the frequency of future executive compensation votes is included, with 'Year' recommended.
Board of directors and corporate governance
Eight director nominees are listed, each recommended for election by the board.
Proxies may vote on other business that arises during the meeting.
Latest events from MiMedx Group
- Record revenue and EBITDA in 2025; 2026 outlook cautious due to Medicare changes.MDXG
Q4 202525 Feb 2026 - Strong growth, innovation, and Medicare reform position MiMedx for expanded market leadership.MDXG
TD Cowen 45th Annual Healthcare Conference3 Feb 2026 - Q2 net sales up 7.3% to $87.2M; adjusted EBITDA margin 23%; outlook remains strong.MDXG
Q2 20242 Feb 2026 - Regulatory reform, product innovation, and M&A drive growth amid reimbursement challenges.MDXG
2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026 - Q3 net sales up 3% to $84M, 22% EBITDA margin, strong cash and raised guidance.MDXG
Q3 202417 Jan 2026 - New reimbursement rules and clinical innovation drive growth and market leadership.MDXG
Stifel 2024 Healthcare Conference13 Jan 2026 - Growth, innovation, and regulatory clarity drive optimism for future expansion and stability.MDXG
Cantor Global Healthcare Conference 20255 Jan 2026 - Strong sales growth, high margins, and LCD-driven optimism despite reimbursement headwinds.MDXG
Q4 202423 Dec 2025 - Annual meeting to vote on directors, compensation, auditor, and equity plan; Board supports all.MDXG
Proxy Filing2 Dec 2025